Opus Genetics
IRD
46 hedge funds and large institutions have $14.7M invested in Opus Genetics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 10 closing their positions.
1,400% more call options, than puts
Call options by funds: $15K | Put options by funds: $1K
235% more capital invested
Capital invested by funds: $4.38M → $14.7M (+$10.3M)
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
21.24% more ownership
Funds ownership: 11.65% → 32.89% (+21%)
7% more funds holding
Funds holding: 43 → 46 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$4.83M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.53M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.31M |
| 4 |
MBAM
Mink Brook Asset Management
West Palm Beach,
Florida
|
+$905K |
| 5 |
BL
Bleichroeder LP
New York
|
+$823K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$121K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$51.9K |
| 3 |
VC
Voss Capital
Houston,
Texas
|
-$45.8K |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$34.9K |
| 5 |
Renaissance Technologies
New York
|
-$24.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Millennium Management
New York
| – | -$14.3K | -11,991 | Closed |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | -$4.87K | -4,088 | Closed |
|
|
RMP
53
Richards, Merrill & Peterson
Spokane,
Washington
| – | -$83 | -70 | Closed |
|
|
KCM
54
Knoll Capital Management
Miami,
Florida
| – | -$53 | -45 | Closed |
|
55
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$12 | -10 | Closed |
|
56
Fidelity Investments
Boston,
Massachusetts
| – | -$1 | -1 | Closed |
|
IRD Hedge Fund Activity: Q1 2025 in Review
46 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2025, worth a combined $14.7M — up 235% from $4.38M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IRD positions and 10 closed out — a net gain of 4 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $4.83M. The largest seller was Citadel Advisors, cutting an estimated $121K.
- 46 institutional investors held Opus Genetics (IRD) as of Q1 2025, up from 43 in Q4 2024.
- Funds reported $14.7M of Opus Genetics stock for Q1 2025, up 235% quarter-over-quarter.
- 14 funds opened new Opus Genetics positions in Q1 2025 and 10 closed out, a net change of +4 holders.
- The largest Opus Genetics buyer in Q1 2025 was Perceptive Advisors, an estimated $4.83M added.
- The largest Opus Genetics seller in Q1 2025 was Citadel Advisors, an estimated $121K sold.
Based on aggregated 13F filings for Q1 2025.